Fort Worth, TX, United States of America

Rupa Doshi


Average Co-Inventor Count = 1.6

ph-index = 2

Forward Citations = 21(Granted Patents)


Location History:

  • Ft. Worth, TX (US) (1998)
  • Fort Worth, TX (US) (1998 - 1999)

Company Filing History:


Years Active: 1998-1999

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Rupa Doshi: Innovator in Retinal Treatment

Introduction

Rupa Doshi is a prominent inventor based in Fort Worth, TX (US). She has made significant contributions to the field of ophthalmology, particularly in the treatment of retinal conditions. With a total of 3 patents, her work has the potential to improve the quality of life for many individuals suffering from retinal diseases.

Latest Patents

Rupa Doshi's latest patents include innovative methods for treating retinal edema using brinzolamide. This invention discloses methods for preventing and treating retinal edema, which is a condition that can lead to vision loss. Additionally, she has developed compositions containing angiostatic compounds aimed at preventing pathological neovascularization, a process that can contribute to various eye diseases.

Career Highlights

Rupa Doshi is currently associated with Alcon Laboratories, Inc., a leading company in eye care. Her work at Alcon has allowed her to focus on groundbreaking research and development in the field of ophthalmology. Her dedication to innovation has positioned her as a key player in the industry.

Collaborations

Throughout her career, Rupa has collaborated with notable colleagues, including Jon C Nixon and Robert J Collier, Jr. These collaborations have further enhanced her research and contributed to the advancement of her inventions.

Conclusion

Rupa Doshi's contributions to retinal treatment through her patents and work at Alcon Laboratories, Inc. highlight her commitment to improving eye health. Her innovative approaches have the potential to make a lasting impact in the field of ophthalmology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…